Yong-Chul Kim Selected Research

4- (2- chloro- 6- (3- chlorobenzylamino)- 9H- purin- 9- yl)- 2,3- dihydroxy- N- methylbicyclo(3.1.0)hexane- 1- carboxamide

9/2010

Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Chul Kim Research Topics

Disease

41	Neoplasms (Cancer) 07/2022 - 09/2005
23	Pain (Aches) 03/2022 - 12/2003
11	Neuralgia (Stump Neuralgia) 03/2022 - 01/2016
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 01/2018
6	Inflammation (Inflammations) 01/2022 - 02/2012
5	Fibrosis (Cirrhosis) 06/2022 - 02/2012
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2016
5	Infections 01/2021 - 06/2007
4	Breast Neoplasms (Breast Cancer) 07/2020 - 09/2013
4	Leukemia 06/2020 - 10/2006
4	Chronic Pain 08/2018 - 04/2011
4	Squamous Cell Carcinoma of Head and Neck 01/2017 - 06/2012
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2018 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 04/2017 - 12/2006
3	Myocarditis (Carditis) 09/2016 - 02/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2013 - 10/2006
2	Hyperalgesia 03/2022 - 01/2017
2	Postherpetic Neuralgia 01/2022 - 05/2018
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2017
2	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 08/2019 - 12/2017
2	Melanoma (Melanoma, Malignant) 10/2018 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 07/2013
2	Mouth Neoplasms (Oral Cancer) 01/2017 - 04/2015
2	Proteinuria 01/2017 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 09/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016 - 11/2015
2	Necrosis 11/2015 - 01/2013
2	Hypotension (Low Blood Pressure) 06/2015 - 01/2013
1	Autosomal Dominant Polycystic Kidney (ADPKD) 07/2022
1	Disease Progression 07/2022
1	Chronic Cough 02/2022
1	Nervous System Diseases (Neurological Disorders) 02/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Headache (Headaches) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Anemia 01/2022
1	Neutropenia 01/2022

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 03/2022 - 12/2006
11	indirubinIBA 03/2019 - 09/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2017 - 11/2009
6	Photosensitizing Agents (Photosensitizers)IBA 01/2017 - 11/2009
6	pheophorbide aIBA 01/2017 - 09/2011
5	Phosphotransferases (Kinase)IBA 07/2022 - 04/2013
5	Pregabalin (Lyrica)FDA Link 03/2022 - 01/2013
5	Purinergic P2X7 ReceptorsIBA 12/2019 - 10/2006
4	Adenosine Triphosphate (ATP)IBA 02/2022 - 10/2006
4	Opioid Analgesics (Opioids)IBA 10/2018 - 08/2015
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017 - 11/2009
4	Peptide Hydrolases (Proteases)FDA Link 09/2016 - 06/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 02/2015
3	Ion Channels (Ion Channel)IBA 03/2022 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2009
3	Biological ProductsIBA 08/2019 - 11/2016
3	Aurora Kinase AIBA 08/2019 - 04/2017
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 01/2013
3	Therapeutic UsesIBA 01/2017 - 06/2012
2	fms-Like Tyrosine Kinase 3IBA 07/2022 - 05/2019
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 09/2010
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 09/2010
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
2	NucleotidesIBA 01/2021 - 07/2005
2	Peptides (Polypeptides)IBA 01/2021 - 04/2015
2	tyrosine receptor (receptor, tyrosine)IBA 06/2020 - 01/2018
2	Lidocaine (Xylocaine)FDA LinkGeneric 08/2019 - 05/2018
2	ProdrugsIBA 07/2018 - 01/2017
2	Analgesics (Analgesic Drugs)IBA 06/2018 - 01/2017
2	Saline SolutionIBA 05/2018 - 09/2010
2	LigandsIBA 01/2018 - 03/2014
2	EnzymesIBA 12/2017 - 04/2011
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016 - 01/2006
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 11/2015 - 06/2012
2	5-nitro-5'-hydroxyindirubin-3'-oximeIBA 11/2015 - 04/2013
2	Docetaxel (Taxotere)FDA Link 03/2014 - 09/2013
2	Fibronectins (Fibronectin)IBA 03/2014 - 10/2012
2	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 01/2013 - 07/2005
2	Protein Kinases (Protein Kinase)IBA 08/2012 - 01/2009
2	NAD (NADH)IBA 04/2011 - 06/2009
1	Protein Glutamine gamma Glutamyltransferase 2IBA 06/2022
1	eltrombopag FDA Link 04/2022
1	compound 17IBA 03/2022
1	Antidepressive Agents (Antidepressants)IBA 03/2022
1	Serotonin (5 Hydroxytryptamine)IBA 03/2022
1	tianeptine (Stablon)IBA 03/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 03/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

18	Therapeutics 03/2022 - 10/2006
7	Photochemotherapy (Photodynamic Therapy) 01/2017 - 11/2009
4	Ligation 03/2022 - 01/2017
4	Intravenous Administration 02/2022 - 06/2012
4	Drug Therapy (Chemotherapy) 01/2017 - 01/2006
2	Epidural Injections 01/2021 - 01/2017
2	Injections 01/2021 - 09/2013
2	Lasers (Laser) 10/2018 - 01/2016
2	Activities of Daily Living (ADL) 06/2018 - 08/2015
2	Conservative Treatment 01/2017 - 04/2016